Chronic drug induced sulphaemoglobinaemia simulating a Hb M disease
Sartori, M.L.; Resegotti, L.; Amè, C.; Capaldi, A.; Trento, M.; Lecchi, M.; Modica, A.; Rabino-Massa, E.; Ricco, G.
Panminerva Medica 23(3): 193-198
1981
ISSN/ISBN: 0031-0808 PMID: 7335370 Document Number: 175329
Document emailed within 1 workday
Related Documents
Kourounakis, P.N.; Rekka, E.; Hadjipetrou-Kourounakis, L. 1991: Restoration of impaired drug metabolism of rats with adjuvant induced disease by two steroids with different influence on drug biotransformation Die Pharmazie 46(10): 727-729Vanhille, P. 1976: Chronic drug-induced kidney diseases Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 21(8): 689-692
Bel, A.; Chambon, A. 1977: Experiments with a new drug in chronic liver diseases, especially alcohol-induced Minerva Dietologica E Gastroenterologica 23(3): 243-248
Laake, K.; Borchgrevink, C.F. 1978: Drug-induced liver disease Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 98(3): 163-164
Brett, W. 1986: Drug induced lung disease New Zealand Medical Journal 99(801): 316-318
Barre, J.; Houin, G.; Brunner, F.; Bree, F.; Tillement, J.P. 1983: Disease-induced modifications of drug pharmacokinetics International Journal of Clinical Pharmacology Research 3(4): 215-226
Ohta, K.; Nagase, H. 2012: Drug-induced interstitial lung disease Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 6): 517-520
Soloshenko, E.N. 1986: Treatment of patients with drug-induced disease Vestnik Dermatologii i Venerologii 3: 54-56
Elie, R.; Gagnon, M.A.; Gauthier, R.; Jéquier, J.C. 1975: Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia L'Union Medicale du Canada 104(6): 909-914
Mackay, M.J. 1987: Drug induced disease as a cause of admission to a country hospital New Zealand Medical Journal 100(832): 592-594
Gracheva, N.M. 1974: Medicamentous agranulocytosis as a manifestation of drug induced disease Terapevticheskii Arkhiv 46(1): 98-105
Factor, S.A.; Molho, E.S.; Podskalny, G.D.; Brown, D. 1995: Parkinson's disease: drug-induced psychiatric states Advances in Neurology 65: 115-138
Barczyk, A.; Pierzchała, W.; Sozańska, E. 2001: Levels of CC-chemokine (MCP-1 alpha, MIP-1 beta) in induced sputum of patients with chronic obstructive pulmonary disease and patients with chronic bronchitis Pneumonologia i Alergologia Polska 69(1-2): 40-49
Greene, P.; Cote, L.; Fahn, S. 1993: Treatment of drug-induced psychosis in Parkinson's disease with clozapine Advances in Neurology 60: 703-706
Wang, X.-L.; Yu, Z.-H.; Chen, S.-H.; Li, Y.-M. 2008: The clinical features and prognosis of drug-induced liver disease Zhonghua Nei Ke Za Zhi 47(5): 385-388
Trüeb, R.; Burg, G. 1992: Drug reaction to amoxicillin simulating toxic pustular dermatosis Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 43(9): 595-596
Costello, J.M.; Becroft, D.M. 1977: Drug reaction simulating malignant lymphoma: a case due to pyrimethamine New Zealand Medical Journal 86(599): 430-432
Dimmitt, S.B.; Stampfer, H.G. 2009: Low drug doses may improve outcomes in chronic disease Medical Journal of Australia 191(9): 511-513
Kino, H. 2003: New drug therapy of chronic obstructive pulmonary disease Nihon Rinsho. Japanese Journal of Clinical Medicine 61(12): 2175-2180
Taylor, C.R. 1990: Diagnostic imaging techniques in the evaluation of drug-induced pulmonary disease Clinics in Chest Medicine 11(1): 87-94